Radium-223 Dichloride Long-term Follow-up Program
Launched by BAYER · Dec 5, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
This long-term follow up study will enroll subjects who will be transferred from selected interventional, company sponsored trials with radium-223 dichloride (feeder trials).
The primary objectives are to define the long term safety profile of radium-223 dichloride (for up to 7 years after the last dose of radium-223 dichloride); to assess the incidence of leukemia, myelodysplastic syndrome, aplastic anemia, and primary bone cancer or any other new primary malignancy; to assess the incidence of bone fractures and bone associated events (e.g., osteoporosis); and, in subjects who receive cyt...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject was previously enrolled in a selected company sponsored feeder trial, and has received at least 1 dose of radium 223 dichloride or placebo in the feeder trial
- Exclusion Criteria:
- • Not applicable to this follow up study
Trial Officials
Bayer Study Director
Study Director
Bayer
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Madrid, , Spain
Belfast, , United Kingdom
Plantation, Florida, United States
Toronto, Ontario, Canada
Gliwice, , Poland
Warszawa, , Poland
Moscow, , Russian Federation
Bialystok, , Poland
Barcelona, , Spain
New Orleans, Louisiana, United States
Jamaica, New York, United States
Syracuse, New York, United States
Detroit, Michigan, United States
Leuven, , Belgium
Tübingen, Baden Württemberg, Germany
München, Bayern, Germany
Plymouth, Devon, United Kingdom
Sutton, Surrey, United Kingdom
Helsinki, , Finland
Erlangen, Bayern, Germany
Barcelona, , Spain
Umeå, , Sweden
Boston, Massachusetts, United States
Hamburg, , Germany
Indianapolis, Indiana, United States
Baltimore, Maryland, United States
Anderlecht, , Belgium
Praha 2, , Czechia
Málaga, , Spain
Kortrijk, , Belgium
Beer Sheva, , Israel
Westmead, New South Wales, Australia
Heidelberg, Victoria, Australia
Nantes, , France
Villejuif, , France
Dresden, Sachsen, Germany
Haifa, , Israel
Obninsk, , Russian Federation
Gdynia, , Poland
Edegem, , Belgium
Poitiers, , France
Tours, , France
Pamplona, , Spain
Shreveport, Louisiana, United States
Tucson, Arizona, United States
Sevilla, , Spain
Seattle, Washington, United States
East Bentleigh, Victoria, Australia
Mainz, Rheinland Pfalz, Germany
Magdeburg, Sachsen Anhalt, Germany
Singapore, , Singapore
Nottingham, Nottinghamshire, United Kingdom
Chai Wan, , Hong Kong
Fitzroy, Victoria, Australia
Toronto, Ontario, Canada
Kuopio, , Finland
Incheon, , Korea, Republic Of
Nimes Cedex 9, , France
Magdeburg, , Germany
Umea, , Sweden
Aachen, Nordrhein Westfalen, Germany
Sapporo, Hokkaido, Japan
Osakasayama, Osaka, Japan
Kanazawa, Ishikawa, Japan
Yokohama, Kanagawa, Japan
Berlin, , Germany
Cottingham, , United Kingdom
Jena, Thüringen, Germany
Adelaide, South Australia, Australia
Taichung, , Taiwan
Bologna, Emilia Romagna, Italy
Milano, Lombardia, Italy
Bremen, , Germany
Watertown, South Dakota, United States
Taipei, , Taiwan
Darlinghurst, New South Wales, Australia
Saint Cloud, , France
Kfar Saba, , Israel
Roma, Lazio, Italy
Jerusalem, , Israel
Petach Tikva, , Israel
Ramat Gan, , Israel
Bordeaux Cedex, , France
Toulouse Cedex 9, , France
Bristol, , United Kingdom
Taunton, Somerset, United Kingdom
Matsuyama, Ehime, Japan
Sendai, Miyagi, Japan
Chiba, , Japan
Kumamoto, , Japan
Osaka, , Japan
Bunkyo Ku, Tokyo, Japan
Fukuoka, , Japan
Afula, , Israel
Hidaka, Saitama, Japan
Milano, Lombardia, Italy
Torino, Piemonte, Italy
Modena, Emilia Romagna, Italy
Busan, , Korea, Republic Of
Saint Cloud, , France
Bodø, , Norway
Guildford, Surrey, United Kingdom
Coventry, Warwickshire, United Kingdom
Koto Ku, Tokyo, Japan
Ulm, Baden Württemberg, Germany
Porto Alegre, Rio Grande Do Sul, Brazil
Sheffield, South Yorkshire, United Kingdom
Trento, Trentino Alto Adige, Italy
Omaha, Nebraska, United States
Taoyuan, , Taiwan
Kita Adachigun, Saitama, Japan
Tampere, , Finland
Palma De Mallorca, Illes Baleares, Spain
Truro, Cornwall, United Kingdom
Santiago, , Chile
Montreal, Quebec, Canada
Oslo, , Norway
Kaohsiung, , Taiwan
Ashland, Kentucky, United States
Wentworthville, New South Wales, Australia
Badalona (Barcelona), Barcelona, Spain
Rostock, Mecklenburg Vorpommern, Germany
Cagliari, Sardegna, Italy
Lørenskog, , Norway
Kurashiki, Okayama, Japan
Seoul, Seoul Teugbyeolsi, Korea, Republic Of
Anchorage, Alaska, United States
São Paulo, Sao Paulo, Brazil
Zrifin, , Israel
Pittsburgh, Pennsylvania, United States
Porto Alegre, Rio Grande Do Sul, Brazil
Barretos, Sao Paulo, Brazil
Miyazaki, , Japan
Forlì Cesena, Emilia Romagna, Italy
Daegu, , Korea, Republic Of
São Paulo, Sao Paulo, Brazil
A Coruña, , Spain
Belo Horizonte, Minas Gerais, Brazil
Freiburg Im Breisgau, Baden Württemberg, Germany
Palma De Mallorca, Illes Baleares, Spain
Barretos/Sp, Sao Paulo, Brazil
Nîmes, , France
Seoul, Seoul Teugbyeolsi, Korea, Republic Of
Chai Wan, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
